LSL Pharma Group (TSXV:LSL) Long-Term Debt : C$5.83 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Long-Term Debt?

LSL Pharma Group's Long-Term Debt for the quarter that ended in Mar. 2024 was C$5.83 Mil.

LSL Pharma Group's quarterly Long-Term Debt increased from Sep. 2023 (C$3.20 Mil) to Dec. 2023 (C$4.73 Mil) and increased from Dec. 2023 (C$4.73 Mil) to Mar. 2024 (C$5.83 Mil).

LSL Pharma Group's annual Long-Term Debt declined from Dec. 2021 (C$7.98 Mil) to Dec. 2022 (C$7.84 Mil) and declined from Dec. 2022 (C$7.84 Mil) to Dec. 2023 (C$4.73 Mil).

LSL Pharma Group Long-Term Debt Historical Data

The historical data trend for LSL Pharma Group's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Long-Term Debt Chart

LSL Pharma Group Annual Data

Trend

Sep20

Dec21

Dec22

Dec23

Long-Term Debt

3.51

7.98

7.84

4.73

LSL Pharma Group Quarterly Data
	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial								5.56	6.06	3.20	4.73	5.83

LSL Pharma Group (TSXV:LSL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

LSL Pharma Group Long-Term Debt Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group (TSXV:LSL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5

Website

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group (TSXV:LSL) Headlines

No Headlines